Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q30244019)
Watch
English
Rheumatoid arthritis.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
review article
1 reference
stated in
Europe PubMed Central
title
Rheumatoid arthritis.
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
main subject
rheumatoid arthritis
1 reference
based on heuristic
inferred from title
author
Josef S Smolen
series ordinal
1
object named as
Josef S Smolen
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
Daniel Aletaha
series ordinal
2
object named as
Daniel Aletaha
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
Iain McInnes
series ordinal
3
object named as
Iain B McInnes
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
language of work or name
English
0 references
publication date
3 May 2016
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
volume
388
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
page(s)
2023-2038
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
issue
10055
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
cites work
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epidemiology and genetics of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Twin concordance rates for rheumatoid arthritis: results from a nationwide study.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
To what extent is the familial risk of rheumatoid arthritis explained by established rheumatoid arthritis risk factors?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Familial aggregation of arthritis-related diseases in seropositive and seronegative rheumatoid arthritis: a register-based case-control study in Sweden
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Psoriasis genetics: breaking the barrier
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Genetics of rheumatoid arthritis contributes to biology and drug discovery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Widespread non-additive and interaction effects within HLA loci modulate the risk of autoimmune diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lack of seroconversion of rheumatoid factor and anti-cyclic citrullinated peptide in patients with early inflammatory arthritis: a systematic literature review.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Autoantibody profiling in patients with very early rheumatoid arthritis: a follow-up study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epigenetics in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cigarette smoking increases the risk of rheumatoid arthritis. Results from a nationwide study of disease-discordant twins.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Personality, socio-economic status and inflammation: cross-sectional, population-based study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Education, self-care, and outcomes of rheumatic diseases: further challenges to the "biomedical model" paradigm
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
HLA molecules, bacteria and autoimmunity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New therapies for treatment of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The pathogenesis of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The microbiome in infectious disease and inflammation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rheumatoid factor, not antibodies against citrullinated proteins, is associated with baseline disease activity in rheumatoid arthritis clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
IgM and IgA rheumatoid factors purified from rheumatoid arthritis sera boost the Fc receptor- and complement-dependent effector functions of the disease-specific anti-citrullinated protein autoantibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serological changes in the course of traditional and biological disease modifying therapy of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rheumatoid factor as a potentiator of anti-citrullinated protein antibody-mediated inflammation in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inflamed target tissue provides a specific niche for highly expanded T-cell clones in early human autoimmune disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Citrulline-specific Th1 cells are increased in rheumatoid arthritis and their frequency is influenced by disease duration and therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hunting for the pathogenesis of rheumatoid arthritis: core-needle biopsy of inguinal lymph nodes as a new research tool
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intracellular signal pathways: potential for therapies.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic strategies for rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Role of cytokines in rheumatoid arthritis: an education in pathophysiology and therapeutics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoclasts are essential for TNF-alpha-mediated joint destruction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metalloproteases and inhibitors in arthritic diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Asymptomatic synovitis precedes clinically manifest arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tenosynovitis and osteoclast formation as the initial preclinical changes in a murine model of inflammatory arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Timing the therapeutic window of opportunity in early rheumatoid arthritis: proposal for definitions of disease duration in clinical trials.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extraarticular manifestations of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of methotrexate-induced accelerated nodulosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-alpha antagonists.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A simplified disease activity index for rheumatoid arthritis for use in clinical practice
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Definition of treatment response in rheumatoid arthritis based on the simplified and the clinical disease activity index
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Remission in rheumatoid arthritis: benefit over low disease activity in patient-reported outcomes and costs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiographic changes in rheumatoid arthritis patients attaining different disease activity states with methotrexate monotherapy and infliximab plus methotrexate: the impacts of remission and tumour necrosis factor blockade
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA s
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How much does Disease Activity Score in 28 joints ESR and CRP calculations underestimate disease activity compared with the Simplified Disease Activity Index?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical trials of new drugs for the treatment of rheumatoid arthritis: focus on early disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
How to report radiographic data in randomized clinical trials in rheumatoid arthritis: guidelines from a roundtable discussion
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metrologic properties of ultrasound versus clinical evaluation of synovitis in rheumatoid arthritis: results of a multicenter, randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In patients with early rheumatoid arthritis, the new ACR/EULAR definition of remission identifies patients with persistent absence of functional disability and suppression of ultrasonographic synovitis.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Doppler ultrasound findings in healthy wrists and finger joints
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Measurement of patient outcome in arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The Effect of Glucocorticoids on Joint Destruction in Rheumatoid Arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proposal for a new nomenclature of disease-modifying antirheumatic drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Very low-dose prednisolone in early rheumatoid arthritis retards radiographic progression over two years: a multicenter, double-blind, placebo-controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiographic outcome after three years of patients with early erosive rheumatoid arthritis treated with intramuscular methotrexate or parenteral gold. Extension of a one-year double-blind study in 174 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of auranofin, gold sodium thiomalate, and placebo in the treatment of rheumatoid arthritis. A controlled clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapies for active rheumatoid arthritis after methotrexate failure
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Can we improve the performance and reporting of investigator-initiated clinical trials? Rheumatoid arthritis as an example
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tuberculosis associated with therapy against tumor necrosis factor alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abatacept Inhibition of T Cell Priming in Mice by Induction of a Unique Transcriptional Profile That Reduces Their Ability to Activate Antigen-Presenting Cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative effectiveness and safety of biological treatment options after tumour necrosis factor α inhibitor failure in rheumatoid arthritis: systematic review and indirect pairwise meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Forget personalised medicine and focus on abating disease activity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of combination therapies in the treatment of rheumatoid arthritis: leflunomide-anti-TNF-alpha versus methotrexate-anti-TNF-alpha
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The JAK-STAT pathway: impact on human disease and therapeutic intervention
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tofacitinib versus methotrexate in rheumatoid arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Baricitinib in Patients with Refractory Rheumatoid Arthritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Infections in patients with rheumatoid arthritis treated with biologic agents
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management of RA medications in pregnant patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Safety of Tumor Necrosis Factor Inhibitors during Pregnancy and Breastfeeding
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Discovery of serum proteomic biomarkers for prediction of response to infliximab (a monoclonal anti-TNF antibody) treatment in rheumatoid arthritis: an exploratory analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Metabolomics for rheumatic diseases: has the time come?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2816%2930173-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(16)30173-8
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
PubMed ID
27156434
1 reference
stated in
Europe PubMed Central
PubMed ID
27156434
retrieved
12 June 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit